CPIX
Cumberland Pharmaceuticals Inc
NASDAQ: CPIX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$4.19
-0.48% today
Updated 2026-04-30
Market cap
$60.72M
P/E ratio
—
P/S ratio
1.36x
EPS (TTM)
$-0.19
Dividend yield
—
52W range
$2 – $6
Volume
1.2M
WallStSmart proprietary scores
41
out of 100
Grade: D
Sell
Investment rating
6.0
Growth
B5.0
Quality
C+2.0
Profitability
F6.3
Valuation
B—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$8.50
+102.86%
12-Month target
—
—
Intrinsic (DCF)
$6.42
Margin of safety
+39.72%
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $3018.00 — positive
+ Revenue growth 31.10% QoQ
+ 39.72% below intrinsic value
Risks
- Thin margins at -6.37%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $42.01M | $39.55M | $37.87M | $44.52M | $44.52M |
| Net income | $-5.57M | $-6.28M | $-6.48M | $-2.84M | $-1.41M |
| EPS | — | — | — | — | $-0.19 |
| Free cash flow | $6.38M | $5.64M | $-791900.00 | $4.83M | $3018.00 |
| Profit margin | -13.26% | -15.88% | -17.11% | -6.37% | -6.37% |
Peer comparison
Smart narrative
Cumberland Pharmaceuticals Inc trades at $4.19. Our Smart Value Score of 41/100 indicates the stock is fair. TTM revenue stands at $44.52M. with profit margins at -6.37%. Our DCF model estimates intrinsic value at $6.42.
Frequently asked questions
What is Cumberland Pharmaceuticals Inc's stock price?
Cumberland Pharmaceuticals Inc (CPIX) trades at $4.19.
Is Cumberland Pharmaceuticals Inc overvalued?
Smart Value Score 41/100 (Grade D, Sell). DCF value $6.42.
What is the price target of Cumberland Pharmaceuticals Inc (CPIX)?
The analyst target price is $8.50, representing +102.9% upside from the current price of $4.19.
What is the intrinsic value of Cumberland Pharmaceuticals Inc (CPIX)?
Based on our DCF model, intrinsic value is $6.42, a +39.7% margin of safety versus $4.19.
What is Cumberland Pharmaceuticals Inc's revenue?
TTM revenue is $44.52M.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.36x
ROE-12.20%
Beta-0.33
50D MA$3.44
200D MA$3.37
Shares out0.01B
Float0.01B
Short ratio—
Avg volume1.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—